Table 1 Characteristics of MDR-TB patients at the start of treatment
Variable | All patients (n = 69) N (%) |
|---|---|
Demographics | |
Age (in years) | |
Median (IQR) | 35 (27–45) |
Sex | |
Female | 21 (30.4%) |
Patients’ medical history at the start of treatment | |
TB treatment history/patient type | |
Category 1 failure | 20 (29.0%) |
Category 2 failure | 37 (53.6%) |
New | 5 (7.3%) |
Relapse | 1 (1.5%) |
Treatment after loss-to-follow up/defaulter | 6 (8.7%) |
Drug resistance profile | |
Resistant to both isoniazid and rifampicin on culture based DST | 30 (43.5%) |
MTB/RIF based on GeneXpert® result | 39 (56.5%) |
HIV status | |
Positive** | 30 (44.5%) |
ART status of HIV positive cases (N = 30) | |
On ART | 27 (90%) |
CD4 Cell count/microliter of blood (N = 30) | |
CD4 cell count is known | 28 (93.3%) |
CD4 cell count is not known | 2 (6.7%) |
Median CD4 cell count (IQR) | 206 (113–364.5) |